Actavis To Acquire Forest Labs For $25 Billion [REPORT]

HFA Padded
Published on
Updated on

Actavis PLC is in talks to acquire Forest Laboratories, Inc. (NYSE:FRX) for $25 billion, compared to a market cap of about $19.3 billion, report Dana Mattioli, Jonathan D. Rockoff, and Dana Cimilluca for The Wall Street Journal. The deal could be officially announced as early as today, though the exact terms are not set and it seems there is still a chance that one of the sides will back out. Recent acquisitions by Actavis, Forest Labs Both pharmaceutical companies have been actively engaged in acquisitions recently. Actavis, which mostly deals with generic medications, bought Warner Chilcott in October 2013 in an…

This content is exclusively for paying members of Hedge Fund Alpha

Log In

Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Don’t have an account?

Subscribe now and get 7 days free!